First Clinical Experience with Solaris Drug-Eluting (DE) Covered Stent: Primary Endpoint Report of the DEScover Randomized Multicenter Trial on the Safety and Efficacy of Solaris DE in Hemodialysis Patients with AV Fistula and Graft Outflow Stenosis

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker's Bureau - Boston Scientific Corporation; W.L. Gore & Associates; Bard Medical; Medtronic</li><li>Grant Support/Research Contract - Merit Medical Systems; SOLARIS INC</li></ul>